-+ 0.00%
-+ 0.00%
-+ 0.00%

B of A Securities Maintains Neutral on Hims & Hers Health, Lowers Price Target to $21

Benzinga·11/20/2026 17:36:25
Listen to the news
B of A Securities analyst Allen Lutz maintains Hims & Hers Health (NYSE:HIMS) with a Neutral and lowers the price target from $26 to $21.